Yoshimichi Ueda
About
In The Last Decade
Yoshimichi Ueda
184 papers receiving 4.2k citations
Peers
Comparison fields: 5 of 129
- Pulmonary and Respiratory Medicine 1.2k
- Molecular Biology 890
- Radiology, Nuclear Medicine and Imaging 845
- Oncology 839
- Surgery 603
Countries citing papers authored by Yoshimichi Ueda
This map shows the geographic impact of Yoshimichi Ueda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yoshimichi Ueda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yoshimichi Ueda more than expected).
Fields of papers citing papers by Yoshimichi Ueda
This network shows the impact of papers produced by Yoshimichi Ueda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yoshimichi Ueda. The network helps show where Yoshimichi Ueda may publish in the future.
Co-authorship network of co-authors of Yoshimichi Ueda
This figure shows the co-authorship network connecting the top 25 collaborators of Yoshimichi Ueda. A scholar is included among the top collaborators of Yoshimichi Ueda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yoshimichi Ueda. Yoshimichi Ueda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 3 | |
| 3 | 2 | |
| 4 | 1 | |
| 5 | 4 | |
| 6 | 0 | |
| 7 | 16 | |
| 8 | 1 | |
| 9 | 38 | |
| 10 | 0 | |
| 11 | 肺腺癌におけるHIF‐1α/HIF‐2α発現とFDG取り込みとの相関 | 0 |
| 12 | 0 | |
| 13 | 0 | |
| 14 | 0 | |
| 15 | 0 | |
| 16 | Microvessel density: correlation with 18F-FDG uptake and prognostic impact in lung adenocarcinomas. | 54 |
| 17 | 5 | |
| 18 | 0 | |
| 19 | In vitro proton magnetic resonance spectroscopic lactate and choline measurements, 18F-FDG uptake, and prognosis in patients with lung adenocarcinoma. | 20 |
| 20 | The effect of SRI 63-675, a competitive platelet-activating factor receptor-antagonist, in the generalized Shwartzman reaction. | 3 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.